Loading...
XNAS
GCTK
Market cap207kUSD
Jul 09, Last price  
0.39USD
1D
6.12%
1Q
-41.54%
IPO
-100.00%
Name

GlucoTrack Inc

Chart & Performance

D1W1MN
XNAS:GCTK chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
42.93%
Rev. gr., 5y
8.45%
Revenues
0k
0000059,775143,167611,689589,46243,488208,000000000
Net income
-19m
L-14.20%
-1,202,296-2,788,446-2,364,339-2,772,307-9,796,8532,980,426-5,842,172-5,409,737-10,328,806-6,715,420-3,516,000-2,696,000-4,067,000-4,435,000-7,097,000-22,597,000-19,388,000
CFO
-15m
L+22.02%
-1,367,837-1,916,113-2,296,989-3,217,767-3,361,645-4,565,224-5,311,830-5,895,119-4,892,277-3,899,087-3,501,000-3,769,000-3,729,000-6,558,000-12,490,000-15,240,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
IPO date
Apr 09, 2013
Employees
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT